Citation Impact

Citing Papers

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
2019 Standout
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Src Continues Aging: Current and Future Clinical Directions
2007
Riding the tiger – physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix
2020
Adaptive Changes Result in Activation of Alternate Signaling Pathways and Acquisition of Resistance to Aromatase Inhibitors
2011
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 Standout
Mechanisms of Endocrine Resistance in Breast Cancer
2010
The hypoxic tumour microenvironment
2018
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Breast cancer
2019 Standout
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
2011
Hypoxia-regulated target genes implicated in tumor metastasis
2012
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
2011
Involvement of Proton-Sensing TDAG8 in Extracellular Acidification-Induced Inhibition of Proinflammatory Cytokine Production in Peritoneal Macrophages
2009
Estrogen receptors outside the nucleus in breast cancer
2007
Genetic Coding Variant in GPR65 Alters Lysosomal pH and Links Lysosomal Dysfunction with Colitis Risk
2016
Prognostic values of S100 family members in ovarian cancer patients
2018
Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: Focus on the role and impact of proteoglycans
2013
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma
2013
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
2014 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
The SIN3A histone deacetylase complex is required for a complete transcriptional response to hypoxia
2017 StandoutNobel
Chemokines
2000 Standout
Targeted Genome-Wide Methylation and Gene Expression Analyses Reveal Signaling Pathways Involved in Ovarian Dysfunction after Developmental EDC Exposure in Rats1
2013
Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway
2016
Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor
2001
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
2011
Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
2009
Inhibition of Cell Surface Expression by Mutant Receptors Demonstrates that D2 Dopamine Receptors Exist as Oligomers in the Cell
2000
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
2010
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Human skeletal muscle fibres: molecular and functional diversity
2000
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Functional food addressing heart health
2015
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
Extracellular matrix structure
2015 Standout
Estrogen signaling pathway and its imaging in human breast cancer
2009
Turning junk into gold: domestication of transposable elements and the creation of new genes in eukaryotes
2006
Fugu: a compact vertebrate reference genome
2000 StandoutNobel
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
β-Arrestin 2-Dependent Angiotensin II Type 1A Receptor-Mediated Pathway of Chemotaxis
2005 StandoutNobel
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
2007 Standout
Treatment for the endocrine resistant breast cancer: Current options and future perspectives
2017
Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
2008
Inflammation and cancer: back to Virchow?
2001 Standout
Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines
2005
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets
2002
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Cholesteryl Ester Transfer Protein in Metabolic Syndrome
2006
Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene
2002
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Seven-transmembrane receptors
2002 StandoutNobel
Selective Autophagy Regulates Insertional Mutagenesis by the Ty1 Retrotransposon in Saccharomyces cerevisiae
2011 StandoutNobel
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Adaptive hypersensitivity to estrogen: Mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment
2005
M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
2020
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
The first 30 years of p53: growing ever more complex
2009 Standout
Hepatocellular carcinoma
2022 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Cellular senescence: from physiology to pathology
2014 Standout
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway
2006
Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations
2002
Cutting Edge: Identification of the Orphan Chemokine Receptor GPR-9-6 as CCR9, the Receptor for the Chemokine TECK
1999
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
The Lymphatic System: Integral Roles in Immunity
2016 Standout
Comparative Genomic Analysis of the Interferon/Interleukin-10 Receptor Gene Cluster
1999
The Estrogen Receptor α Pathway Induces OncogenicWip1Phosphatase Gene Expression
2009
Bisphenol a regulates the estrogen receptor alpha signaling in developing hippocampus of male rats through estrogen receptor
2014
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
2000 Standout
The Interleukin-8 Pathway in Cancer
2008 Standout
The Kaposi's Sarcoma–related Herpesvirus (KSHV)-encoded Chemokine vMIP-I is a Specific Agonist for the CC Chemokine Receptor (CCR)8
1999
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Oral Cholesteryl Ester Transfer Protein (CETP) Inhibitors:  A Potential New Approach for Treating Coronary Artery Disease
2005
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin‐like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells
2013
Trace amines: Identification of a family of mammalian G protein-coupled receptors
2001
Thyroid Hormone Regulation of Metabolism
2014 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: meta-analysis
2021
Characterization of Human T Cells That Regulate Neutrophilic Skin Inflammation
2004
Minireview: Extranuclear Steroid Receptors: Roles in Modulation of Cell Functions
2010
G protein-coupled receptors in natural killer cells
2003
The Metabolic Syndrome
2008 Standout
The Biology of Chemokines and their Receptors
2000 Standout
Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK.
1999
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Cytosolic Phospholipase A2 Activation Correlates with HER2 Overexpression and Mediates Estrogen-Dependent Breast Cancer Cell Growth
2010
Trafficking of G Protein–Coupled Receptors
2006 StandoutNobel

Works of Ping Fan being referenced

Breast Cancer Cell Apoptosis with Phytoestrogens Is Dependent on an Estrogen-Deprived State
2014
Up-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancer
2014
Cloning and Characterization of a Novel Human Chemokine Receptor
1998
Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells
2005
Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women
2019
Role of receptor complexes in the extranuclear actions of estrogen receptor α in breast cancer
2006
Cloning, Mapping, and Tissue Distribution of a Human Homologue of the Mouse Jerky Gene Product
1997
Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions
2012
Cloning, Characterization, and Mapping of Human Homolog of Mouse T-Cell Death-Associated Gene
1998
Isolation, Characterization, and Mapping of Two Human Potassium Channels
1997
Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells
2007
Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells
2009
Adaptation to Estradiol Deprivation Causes Up-Regulation of Growth Factor Pathways and Hypersensitivity to Estradiol in Breast Cancer Cells
2008
Cloning of a Putative Human Neurotransmitter Receptor Expressed in Skeletal Muscle and Brain
1998
Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration
2005
Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits
2003
Overexpression of membrane-type 2 matrix metalloproteinase induced by hypoxia-inducible factor-1α in pancreatic cancer: Implications for tumor progression and prognosis
2014
Effect of the beta-3 adrenergic receptor Trp64Arg and uncoupling protein 1–3826 A > G genotypes on lipid and apolipoprotein levels in overweight/obese and non-obese Chinese subjects
2015
Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells
2008
Long-term Treatment with Tamoxifen Facilitates Translocation of Estrogen Receptor α out of the Nucleus and Enhances its Interaction with EGFR in MCF-7 Breast Cancer Cells
2007
Anterior approach to improve the long-term outcome in patients with large-size hepatocellular carcinoma having liver resection
2016
Mechanisms of Resistance to Structurally Diverse Antiestrogens Differ under Premenopausal and Postmenopausal Conditions: Evidence from in Vitro Breast Cancer Cell Models
2009
Inhibition of Cholesteryl Ester Transfer Protein Activity by JTT-705 Increases Apolipoprotein E–Containing High-Density Lipoprotein and Favorably Affects the Function and Enzyme Composition of High-Density Lipoprotein in Rabbits
2004
A new look at molecular biology of breast cancer
2018
Rankless by CCL
2026